dc.contributor.author | Mortensen, Jan Helge Seglem | en_US |
dc.contributor.author | Øyen, Nina | en_US |
dc.contributor.author | Fomina, Tatiana | en_US |
dc.contributor.author | Melbye, Mads | en_US |
dc.contributor.author | Tretli, Steinar | en_US |
dc.contributor.author | Vollset, Stein Emil | en_US |
dc.contributor.author | Bjørge, Tone | en_US |
dc.date.accessioned | 2017-08-04T09:07:12Z | |
dc.date.available | 2017-08-04T09:07:12Z | |
dc.date.issued | 2016 | |
dc.Published | Mortensen JH, Øyen N, Fomina T, Melbye M, Tretli S, Vollset SE, Bjørge T. Supplemental folic acid in pregnancy and childhood cancer risk. British Journal of Cancer. 2016;114:71-75 | eng |
dc.identifier.issn | 0007-0920 | |
dc.identifier.uri | https://hdl.handle.net/1956/16208 | |
dc.description.abstract | Background: We investigated the association between supplemental folic acid in pregnancy and childhood cancer in a nationwide study of 687 406 live births in Norway, 1999–2010, and 799 children diagnosed later with cancer. Methods: Adjusted hazard ratios (HRs) compared cancer risk in children by approximated periconceptional folic acid levels (folic acid tablets and multivitamins (0.6 mg), only folic acid (0.4 mg), only multivitamins (0.2 mg)) and cancer risk in unexposed. Results: Any folic acid levels were not associated with leukemia (e.g., high-level folic acid HR 1.25; 95% CI 0.89–1.76, PTrend 0.20), lymphoma (HR 0.96; 95% CI 0.42–2.21, PTrend 0.51), central nervous system tumours (HR 0.68; 95% CI 0.42–1.10, PTrend 0.32), neuroblastoma (HR 1.05; 95% CI 0.53–2.06, PTrend 0.85), Wilms’ tumour (HR 1.16; 95% CI 0.52–2.58, PTrend 0.76), or soft-tissue tumours (HR 0.77; 95% CI 0.34–1.75, PTrend 0.90). Conclusions: Folic acid supplementation was not associated with risk of major childhood cancers. | en_US |
dc.language.iso | eng | eng |
dc.publisher | BMJ | eng |
dc.rights | Attribution CC BY-NC-SA | eng |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/ | eng |
dc.subject | folic acid supplementation | eng |
dc.subject | Pregnancy | eng |
dc.subject | childhood cancer | eng |
dc.subject | Cohort study | eng |
dc.title | Supplemental folic acid in pregnancy and childhood cancer risk | en_US |
dc.type | Peer reviewed | |
dc.type | Journal article | |
dc.date.updated | 2017-05-10T11:27:38Z | |
dc.description.version | publishedVersion | en_US |
dc.rights.holder | Copyright 2016 Cancer Research UK | |
dc.identifier.doi | https://doi.org/10.1038/bjc.2015.446 | |
dc.identifier.cristin | 1363594 | |
dc.source.journal | British Journal of Cancer | |